arrow
M

Mary M. Horowitz

medical college of wisconsin
H指数:128
被引数:5.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial

供者检索与选择策略以促进不同供者检索预后组间可比的移植率:BMT CTN 1702试验报告

2026-01-150
PRE
Reduced-Intensity Haploidentical Bone Marrow Transplantation in Children with Severe Sickle Cell Disease: BMT CTN 1507

低强度半相合骨髓移植在重症镰状细胞病儿童中的应用:BMT CTN 1507

2026-01-010
OAAI
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial

基于供者搜索预后对同种异体细胞移植的准入:BMT CTN 1702试验

2025-11-080
PRE
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响

2025-07-030
OAAI
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice

重症再生障碍性贫血中早期替代供者造血干细胞移植:将证据转化为实践中的差距与机遇

2025-06-260
OAAI
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

新型异基因移植受者健康评估风险模型:BMT-CTN 1704

2025-01-010
OAAI
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
2024-09-270
OAAI
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
2024-05-277
PRE
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
2024-05-095
OAAI
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

BMT CTN 0601试验中严重镰状细胞病的无关供体移植后的长期结果

2024-02-111
PRE
Post-Transplantation CyclophosphamideBased Graft-versus-Host Disease Prophylaxis

移植后基于环磷酰胺的移植物抗宿主病预防

2023-06-22167
OA
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
2023-05-0116
OAAI
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

使用移植后环磷酰胺的不匹配的无关骨髓供体移植接受者的三年结果: 来自国家骨髓供体计划赞助的前瞻性临床试验的随访

2023-03-0127
OAAI